Scotia Capital’s Lineage Cell Therapeutics LCTX Stock Holding History

Scotia Capital’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$24.3K	Hold	26,750	–	–	﹤0.01%	851
2025 Q1	$12.1K	Hold	26,750	–	–	﹤0.01%	840
2024 Q4	$13.4K	Buy	26,750 +10,000	+60%	+$5.02K	﹤0.01%	849
2024 Q3	$15.2K	Hold	16,750	–	–	﹤0.01%	825
2024 Q2	$16.7K	Hold	16,750	–	–	﹤0.01%	819
2024 Q1	$24.8K	Hold	16,750	–	–	﹤0.01%	818
2023 Q4	$18.3K	Hold	16,750	–	–	﹤0.01%	784
2023 Q3	$19.8K	Hold	16,750	–	–	﹤0.01%	761
2023 Q2	$23.6K	Hold	16,750	–	–	﹤0.01%	771
2023 Q1	$25.1K	Hold	16,750	–	–	﹤0.01%	771
2022 Q4	$19.6K	Sell	16,750 -16,750	-50%	-$19.6K	﹤0.01%	770
2022 Q3	$38K	Hold	33,500	–	–	﹤0.01%	756
2022 Q2	$53K	Sell	33,500 -266	-0.8%	-$421	﹤0.01%	778
2022 Q1	$52K	Buy	33,766 +266	+0.8%	+$410	﹤0.01%	853
2021 Q4	$82K	Sell	33,500 -266	-0.8%	-$651	﹤0.01%	840
2021 Q3	$85K	Buy	33,766 +266	+0.8%	+$670	﹤0.01%	827
2021 Q2	$95K	Hold	33,500	–	–	﹤0.01%	798
2021 Q1	$79K	Sell	33,500 -23	-0.1%	-$54	﹤0.01%	767
2020 Q4	$59K	Buy	33,523 +425	+1%	+$748	﹤0.01%	728
2020 Q3	$31K	Sell	33,098 -402	-1%	-$377	﹤0.01%	685
2020 Q2	$29K	Sell	33,500 -13,000	-28%	-$11.3K	﹤0.01%	611
2020 Q1	$39K	Buy	46,500 +13,000	+39%	+$10.9K	﹤0.01%	616
2019 Q4	$30K	Hold	33,500	–	–	﹤0.01%	722
2019 Q3	$33K	Hold	33,500	–	–	﹤0.01%	706
2019 Q2	$37K	Hold	33,500	–	–	﹤0.01%	710
2019 Q1	$44K	Hold	33,500	–	–	﹤0.01%	682
2018 Q4	$31K	Sell	33,500 -4,791	-13%	-$4.43K	﹤0.01%	641
2018 Q3	$79K	Buy	38,291 +10,287	+37%	+$21.2K	﹤0.01%	693
2018 Q2	$66K	Hold	28,004	–	–	﹤0.01%	648
2018 Q1	$66K	Buy	28,004 +8,173	+41%	+$19.3K	﹤0.01%	680
2017 Q4	$37K	Hold	19,831	–	–	﹤0.01%	682
2017 Q3	$49K	Buy	19,831 +3,200	+19%	+$7.91K	﹤0.01%	663
2017 Q2	$46K	Hold	16,631	–	–	﹤0.01%	649
2017 Q1	$50K	Hold	16,631	–	–	﹤0.01%	658
2016 Q4	$53K	Hold	16,631	–	–	﹤0.01%	644
2016 Q3	$57K	Buy	+16,631	New	+$57K	﹤0.01%	621